RECALIBRATE YOUR HEALTHCARE STRATEGY
Learn 4 strategic pivots for 2025 and beyond.
Learn more

Library

| Daily Briefing

Around the nation: FDA approves first e-cigarette


FDA granted its first approval to an electronic cigarette, in today's bite-sized hospital and health industry news from California, Illinois, and Maryland.

  • California: Amid a staffing shortage, the Los Angeles Unified School District (LAUSD) extended its deadline for staff to receive the Covid-19 vaccine from Oct. 15 to Nov. 15. As of Sept. 27, a fifth of employees were still unvaccinated. "We don't want people to be out of jobs," said interim superintendent, Megan Reilly. "Our employees are one of the strongest assets that we have." (Chen, Axios, 10/12)
  • Illinois: CommonSpirit Health on Tuesday announced that its CEO, Lloyd Dean, plans to retire in the summer of 2022. According to Dean, the organization's board has known about his plan to retire for some time and set criteria for the transition that have now been met. "While we haven't talked about it publicly up until this point, that was always the plan of the board and always the plan of myself," said Dean. "I think that we set some criteria for when that would happen and I'm excited that we have met that threshold." (Bannow, Modern Healthcare, 10/12)
  • Maryland: FDA on Tuesday announced that R.J. Reynolds Vapor Company's Vuse Solo device and its affiliated tobacco-flavored cartridges passed the premarket approval process—making it the first electronic nicotine delivery system to gain FDA approval. In addition, R.J. Reynolds received rejection notices for 10 other applications for unspecified flavored products. Meanwhile, FDA said that an application for Vuse Solo's menthol-flavored products is still under review. (Phend, MedPage Today, 10/12)

SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

MORE FROM TODAY'S DAILY BRIEFING

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.